Financial Ratios

RAJNISH WELLNESS LTD.

NSE : NABSE : 541601ISIN CODE : INE685Z01033Industry : Pharmaceuticals & DrugsHouse : Private
BSE1.220.05 (+4.27 %)
PREV CLOSE ( ) 1.17
OPEN PRICE ( ) 1.22
BID PRICE (QTY) 1.22 (19270385)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1315540
TODAY'S LOW / HIGH ( )1.22 1.22
52 WK LOW / HIGH ( ) 1.0211.35
NSE
This Company is not listed in NSE
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)0.010.010.370.21-1.30
   CEPS(Rs)0.010.010.010.00-0.02
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.091.0821.0446.4946.28
   Tax Rate(%)28.5327.2528.5813.681.31
Margin Ratios
   Core EBITDA Margin(%)2.60-4.30-0.36-23.730.98
   EBIT Margin(%)2.572.593.153.141.98
   Pre Tax Margin(%)1.892.452.080.87-4.49
   PAT Margin (%)1.351.781.480.75-4.43
   Cash Profit Margin (%)1.381.831.511.16-4.04
Performance Ratios
   ROA(%)1.010.691.130.29-1.88
   ROE(%)1.240.881.790.46-2.78
   ROCE(%)2.171.082.711.400.97
   Asset Turnover(x)0.750.390.760.390.42
   Sales/Fixed Asset(x)236.3289.27102.0754.6056.54
   Working Capital/Sales(x)1.190.810.930.500.52
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.010.010.020.02
   Receivable days128.14257.12227.79393.83407.72
   Inventory Days30.9741.2922.0629.2352.81
   Payable days47.7436.4824.5039.8451.68
Valuation Parameters
   PER(x)484.332766.677.500.780.00
   PCE(x)471.712699.26221.4333.86-15.68
   Price/Book(x)5.9515.403.990.240.40
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)6.5649.783.641.031.19
   EV/Core EBITDA(x)252.501884.64114.6628.9050.30
   EV/EBIT(x)255.591919.82115.5132.7360.09
   EV/CE(x)5.6713.822.750.400.49
   M Cap / Sales6.5049.393.340.390.63
Growth Ratio
   Net Sales Growth(%)196.93-2.3198.16-2.95-67.01
   Core EBITDA Growth(%)192.30-18.7676.8046.14-95.23
   EBIT Growth(%)194.16-19.6598.7654.14-95.97
   PAT Growth(%)124.5617.37293.18116.38-114.37
   EPS Growth(%)123.33-98.3974.75116.38-114.37
Financial Stability Ratios
   Total Debt/Equity(x)0.060.120.410.400.36
   Current Ratio(x)4.866.585.814.905.48
   Quick Ratio(x)4.305.925.464.745.30
   Interest Cover(x)3.7618.002.931.380.31
   Total Debt/Mcap(x)0.010.010.101.640.88

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.